11/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

11/2024

Nov 28, 2024, 17:10 | Opinion
Ajay Major: BAFF-R CAR-T - Promising Outcomes in Refractory B-Cell Lymphomas
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 28, 2024, 16:34 | Blog
Roni Shouval: Insights into Renal Injury in CAR-T Therapy from Global FDA Reports
Roni Shouval , Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on…
Nov 28, 2024, 16:30 | Blog
Ajay Major: Bridging Radiotherapy and Systemic Therapy - Impact on Outcomes Before Axi-Cel
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 28, 2024, 16:24 | Blog
“Researchers ID key mechanism behind drug-resistant prostate cancer“ - Weill Cornell Medicine Pathology
Weill Cornell Medicine Pathology shared on X: “Nice FingerLakes1 news article ‘Researchers ID key mechanism behind…
Nov 28, 2024, 15:42 | Insight
Novartis Kisqali Receives European Commission Approval for HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Novartis recently announced that the European Commission (EC) has approved Kisqali® (ribociclib) in combination with…
Nov 28, 2024, 15:29 | Blog
Honoring the Legacy of Faustine Ndugulile
Dr. Faustine Engelbert Ndugulile, the Regional Director (RD)-elect for the WHO African Region, has passed…
Nov 28, 2024, 14:37 | Insight
25 Years of Advancing Hematologic Malignancies: The Lymphoma, Leukemia and Myeloma Congress
Lymphoma, Leukemia and Myeloma Congress shared a post on X: “This Thanksgiving, we're especially grateful…
Nov 28, 2024, 14:04 | Blog
OncoInfluencers to Follow on Social Media: Dr. Eric K. Singhi
We’re excited to feature Dr. Eric K. Singhi, a distinguished expert in thoracic and head…
Nov 28, 2024, 12:51 | Blog
Liver Transplantation for Cholangiocarcinoma After Chemotherapy and SIRT
Arndt Vogel shared on X: "Liver Transplantation for Cholangiocarcinoma After Chemotherapy and SIRT: An Intention-To-Treat Study …
Nov 28, 2024, 12:48 | Blog
MASCC - NCI-funded T32 Clinical and Translational Cancer Control Research Training Program
MASCC shared on X: "The NCI-funded T32 Clinical and Translational Cancer Control Research Training Program…
All: 2346 Posts: 201 - 210
Special Coverage